Clinical Trial Update: A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial of ABT-751 in patients with Non-Small Cell Lung Cancer, with the trial status noted as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ABT-751 (ABT-751)

Snippet

Sponsor: Abbott | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED